Healthequity Inc (HQY) Expected to Post Earnings of $0.28 Per Share

Analysts expect Healthequity Inc (NASDAQ:HQY) to post earnings of $0.28 per share for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Healthequity’s earnings, with estimates ranging from $0.25 to $0.30. Healthequity posted earnings per share of $0.19 during the same quarter last year, which indicates a positive year over year growth rate of 47.4%. The firm is scheduled to announce its next quarterly earnings report on Tuesday, June 5th.

According to Zacks, analysts expect that Healthequity will report full-year earnings of $1.01 per share for the current fiscal year, with EPS estimates ranging from $0.90 to $1.04. For the next fiscal year, analysts forecast that the business will post earnings of $1.27 per share, with EPS estimates ranging from $1.20 to $1.34. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that cover Healthequity.

How to Become a New Pot Stock Millionaire

Healthequity (NASDAQ:HQY) last announced its quarterly earnings data on Monday, March 19th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Healthequity had a net margin of 20.64% and a return on equity of 13.47%. The business had revenue of $60.44 million during the quarter, compared to analysts’ expectations of $58.46 million.

Several analysts have commented on HQY shares. BidaskClub cut shares of Healthequity from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. SunTrust Banks lifted their price objective on shares of Healthequity to $70.00 and gave the company a “buy” rating in a research note on Tuesday, March 20th. Oppenheimer lifted their price objective on shares of Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. JPMorgan Chase decreased their price objective on shares of Healthequity from $52.00 to $51.00 and set an “overweight” rating for the company in a research note on Wednesday, January 24th. Finally, Barrington Research lifted their price objective on shares of Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Two investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has issued a strong buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $66.20.

NASDAQ HQY traded down $0.15 on Wednesday, hitting $60.39. 669,128 shares of the company’s stock traded hands, compared to its average volume of 706,310. Healthequity has a 1-year low of $40.21 and a 1-year high of $68.75. The stock has a market cap of $3,690.04, a price-to-earnings ratio of 111.11, a PEG ratio of 2.42 and a beta of 1.39.

In related news, insider Berkley Capital, Llc sold 350,000 shares of the business’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $52.12, for a total value of $18,242,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, VP Ashley Dreier sold 71,157 shares of the business’s stock in a transaction on Thursday, March 22nd. The stock was sold at an average price of $65.48, for a total transaction of $4,659,360.36. Following the completion of the sale, the vice president now directly owns 21,059 shares of the company’s stock, valued at approximately $1,378,943.32. The disclosure for this sale can be found here. Over the last quarter, insiders sold 734,884 shares of company stock valued at $39,401,195. Company insiders own 19.00% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Zions Bancorporation purchased a new stake in Healthequity in the 3rd quarter worth $119,000. Catalyst Capital Advisors LLC purchased a new stake in Healthequity in the 4th quarter worth $149,000. Two Sigma Securities LLC purchased a new stake in Healthequity in the 4th quarter worth $208,000. Exane Derivatives increased its holdings in Healthequity by 78.6% in the 4th quarter. Exane Derivatives now owns 4,682 shares of the company’s stock worth $218,000 after acquiring an additional 2,060 shares in the last quarter. Finally, Private Advisor Group LLC purchased a new stake in Healthequity in the 3rd quarter worth $241,000. 99.38% of the stock is owned by institutional investors.

ILLEGAL ACTIVITY WARNING: “Healthequity Inc (HQY) Expected to Post Earnings of $0.28 Per Share” was first published by WKRB News and is the sole property of of WKRB News. If you are viewing this story on another publication, it was copied illegally and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be viewed at https://www.wkrb13.com/2018/04/02/healthequity-inc-hqy-expected-to-post-earnings-of-0-28-per-share.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply